IL1B and COVID-19: The phenomenon, called post-acute sequelae of COVID-19 (PASC), may be more closely linked to persistent cytokine dysregulation, including sustained IL-1β activity and elevated levels of IL-6 and TNF-α, rather than the emergence of post-COVID-19 autoantibodies [72].